封面
市場調查報告書
商品編碼
1212475

醫療用外骨骼的全球市場

Medical Exoskeleton

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫療用外骨骼的全球市場2030年前將達到58億美元

在COVID-19後改變的商務環境中,2022年9億5,500萬美元的醫療用外骨骼的全球市場,在2022年~2030年預計將以年複合成長率25.2%增長,2030年修訂58億美元。本報告所分析之市場區隔之一的硬體設備將記錄年複合成長率22.3%,到分析期間結束時將達到28億美元。考慮疫情後的復甦,軟體領域今後8年的年複合成長率將修正為28.7%。

美國市場估算為2億9,600萬美元,中國則將以年複合成長率23.5%的速度成長預測

美國的醫療用外骨骼市場在2022年估算為2億9,600萬美元。作為世界第2大經濟大國的中國,在2022年~2030年複合成長率預計將為23.5%,2030年達到9億1,410萬美元的市場規模。其他熱門的地區市場有日本和加拿大,在2022年~2030年預計將各以22.6%和21.1%的速度成長。在歐洲市場中,德國預計將以年複合成長率15.2%成長。

調查對像企業範例

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG(A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22233

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Medical Exoskeleton Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Medical Exoskeleton estimated at US$955 Million in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 25.2% over the period 2022-2030. Hardware, one of the segments analyzed in the report, is projected to record 22.3% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 28.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $296 Million, While China is Forecast to Grow at 23.5% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$296 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 23.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 22.6% and 21.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 34 Featured):

  • Bionik Laboratories Corp
  • B-TEMIA Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Gogoa Mobility Robots SL
  • Hocoma AG (A Subsidiary of DIH Technologies)
  • Parker Hannifin Corp
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • US Bionics
  • Wearable Robotics SRL

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Exoskeleton - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Medical Exoskeleton by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Powered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Powered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Mobile by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Mobile by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Stationary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Stationary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Medical Exoskeleton Market Analysis of Annual Sales in US$ for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • JAPAN
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • CHINA
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 52: China 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 55: China 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 58: China 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • EUROPE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medical Exoskeleton by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Medical Exoskeleton by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 67: Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 70: Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • FRANCE
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 73: France 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 76: France 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 79: France 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • GERMANY
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 82: Germany 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 85: Germany 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 88: Germany 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 91: Italy 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 94: Italy 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 97: Italy 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 100: UK 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 103: UK 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 106: UK 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 112: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 115: Rest of Europe 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Medical Exoskeleton Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 118: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 121: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 124: Asia-Pacific 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Component - Hardware and Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Medical Exoskeleton by Component - Hardware and Software Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 127: Rest of World 18-Year Perspective for Medical Exoskeleton by Component - Percentage Breakdown of Value Sales for Hardware and Software for the Years 2012, 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Type - Powered and Passive - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Medical Exoskeleton by Type - Powered and Passive Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 130: Rest of World 18-Year Perspective for Medical Exoskeleton by Type - Percentage Breakdown of Value Sales for Powered and Passive for the Years 2012, 2023 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Medical Exoskeleton by Mobility - Mobile and Stationary - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Medical Exoskeleton by Mobility - Mobile and Stationary Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2021 and % CAGR
    • TABLE 133: Rest of World 18-Year Perspective for Medical Exoskeleton by Mobility - Percentage Breakdown of Value Sales for Mobile and Stationary for the Years 2012, 2023 & 2030

IV. COMPETITION